go back

Sotrovimab Infusion, Home or Residence

Tennessee rates for HCPCS M0248

Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the COVID-19 public health emergency

Rates data updated July 2026.

Facilitymedian $4,677 · 10th–90th $4,677$4,6770%50%100%$4,677$5.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Lucent Health
Setting
Facility
Modifier
Global
Typical Low
$4,677.35
Median
$4,677.35
Typical High
$4,677.35